Innovation
in Nucleic Acid Therapeutics for Human Health

Pipeline

  • HOME
  • R & D
  • OliX Pipeline
  • Pipeline

 To overcome limitations in stability & delivery and minimize siRNA’s toxicity,  
OliX concentrates on the development of RNAi therapeutics for dermal,
ophthalmic and pulmonary diseases, which can be locally administered